• Users Online: 3102
  • Print this page
  • Email this page

  Table of Contents  
Year : 2016  |  Volume : 7  |  Issue : 4  |  Page : 332-334  

Pyoderma gangrenosum associated with mantle cell lymphoma

Department of Dermatology, Venereology and Leprosy, Veer Surendra Sai Medical College, Burla, Odisha, India

Date of Web Publication5-Jul-2016

Correspondence Address:
Swetalina Pradhan
QR. No. D/6, Near PWD Office, Burla, Sambalpur, Odisha
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2229-5178.185467

Rights and Permissions

How to cite this article:
Padhi T, Pradhan S, Pradhan K, Kumar SK. Pyoderma gangrenosum associated with mantle cell lymphoma. Indian Dermatol Online J 2016;7:332-4

How to cite this URL:
Padhi T, Pradhan S, Pradhan K, Kumar SK. Pyoderma gangrenosum associated with mantle cell lymphoma. Indian Dermatol Online J [serial online] 2016 [cited 2021 Dec 4];7:332-4. Available from: https://www.idoj.in/text.asp?2016/7/4/332/185467


Pyoderma gangrenosum (PG) is as an idiopathic, ulcerative, chronic inflammatory skin disease of uncertain etiology. We report a case of PG associated with mantle cell lymphoma (MCL).

A 40-year-old female patient presented with a large ulcer on the anterolateral aspect of left lower leg along with fever, weakness, cervical and axillary lymphadenopathy, severe anemia, and a history of repeated blood transfusion in the past. There was no history of any change in bowel habits or joint pain or history of any drug intake. The cutaneous lesion started as a small nodule, which subsequently eroded to form an ulcer of size 12 cm × 10 cm within 20 days. The ulcer was indurated, tender with an elevated bluish border, undermined edge, and multiple sieve-like openings discharging serosanguinous fluid [Figure 1]a and [Figure 1]b. Except splenomegaly, findings of other systemic examinations were unremarkable. Laboratory investigation revealed the following: Hb - 4 gm%, total leukocyte count - 90,000/mm 3, predominantly normocytic normochromic red blood cells, thrombocytopenia, and marked leukocytosis with presence of 70% blast cells. Fine-Needle Aspiration cytology of cervical lymph node showed monomorphic population of small lymphoid cells with mitosis and numerous small lymphocytes with scanty cytoplasm and round nuclei, suggestive of the cytological picture of MCL. Mantle cells were also found in the biopsy of axillary lymph node [Figure 2]c and [Figure 2]d. Flow cytometric analysis detected an atypical population of lymphoid cells (73% of the total) showing coexpression of CD5 and CD19 with kappa light chain restriction, expressing CD20, CD22, CD79a, CD79b, surface IgM, and CD45 and was negative for CD23, CD10, and CD103 [Figure 3]. Overall findings were consistent with a B-cell lymphoproliferative disorder, the leukemic phase of MCL.
Figure 1: (a and b) Ulcer with elevated bluish border, undermined edge, and multiple sieve-like openings discharging serosanguinous fluid. (c and d) Healing of ulcer after 7-10 days of treatment

Click here to view
Figure 2: (a and b) Histopathology of ulcer ×10 and ×40, respectively, showing dense diffuse infiltration of acute and chronic inflammatory cells. (c and d) Histopathology of lymph node ×40 and ×100, respectively, showing monomorphic population of small lymphoid cells with mitosis and mantle cells. H and E Stain

Click here to view
Figure 3: Flow cytometry analysis report

Click here to view

Punch biopsy from the edge of the ulcer showed a dense diffuse infiltration of acute and chronic inflammatory cells mostly neutrophils along with necrosis of the epithelium [Figure 2]a and [Figure 2]b. On the basis of laboratory investigation and histopathological study, a diagnosis of PG secondary to MCL was made. The patient was treated with oral dapsone 100 mg/day (G6PD was normal); prednisolone 40 mg/day; topical clobetasol propionate ointment, and moist vaseline gauze dressing along with three units of blood transfusion. The ulcer started healing and decreased in size within 7–10 days [Figure 1]c and [Figure 1]d and the patient was referred to a higher center for further management of MCL.

PG is a rare chronic destructive inflammatory skin disease, which begins as a tender erythematous nodule, then forms a pustule, followed by rapid central necrosis characterized by edematous and dusky overhanging borders with a surrounding margin of erythema. It is often associated with various systemic diseases, most notably inflammatory bowel disease (IBD) and also appears in the setting of various malignancies.[1] The most common reported malignancy is acute myeloid leukemia and the association with solid tumors has also been reported.[2]

The etiology of PG is unknown but tumor necrosis factor-α (TNF-α) is believed to play a major role, possibly through its stimulatory action on the neutrophil chemoattractant, IL-8.[3],[4] Similarly, higher than normal levels of cytokines such as TNF-α, IL-8, and vascular endothelial growth factor (VEGF) are often reported in various hematological malignancies.

The recommended firstline treatment in PG is steroids or other immunosuppressive drugs.[5] In our patient it was the ulcerative variant of PG secondary to MCL, which responded dramatically to oral prednisolone and dapsone. As she was referred to an oncology center, we lost her to follow up and could not ascertain what therapy she received and whether the ulcer recurred.

The co-existence of PG and MCL in our case could be attributed to common cytokine milieu such as TNF-α, IL-8, and VEGF in both these conditions and hence the presence of MCL might have induced the occurrence of PG. We report the case for its rarity as PG occurring in the setting of MCL has not been reported in the scientific literature.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Maverakis E, Goodarzi H, Wehrli LN, Ono Y, Garcia MS. The etiology of paraneoplastic autoimmunity. Clin Rev Allergy Immunol 2012;42:135-44.  Back to cited text no. 1
Duchnowska R, Ziajka E, Góralska A, Grala B. Recurrent pyoderma gangrenosum precipitated by breast cancer: A case report and review of the literature. J Med Case Rep2014;8:226.  Back to cited text no. 2
Palombella VJ, Rando OJ, GoldbergAL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa-B1 precursor protein and the activation of NF-kappa-B. Cell 1994;78:773-85.  Back to cited text no. 3
Siebenlist U, Franzoso G, Brown K. Structure, regulation, and function of NF-kB. Annu Rev Cell Biol 1995;10:405-55.  Back to cited text no. 4
Gilmour E, Stewart D. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis. Br J Dermatol 2001;144:397-400.  Back to cited text no. 5


  [Figure 1], [Figure 2], [Figure 3]

This article has been cited by
1 Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review
Roberto Maglie, Giovanni Genovese, Farzan Solimani, Alba Guglielmo, Alessandro Pileri, Francesca Portelli, Michael Hertl, Angelo Valerio Marzano, Emiliano Antiga
American Journal of Clinical Dermatology. 2020; 21(6): 833
[Pubmed] | [DOI]
2 Pyoderma gangrenosum in hematologic malignancies: A systematic review
Carmen M. Montagnon, Elizabeth A. Fracica, Archna A. Patel, Michael J. Camilleri, M. Hassan Murad, David Dingli, David A. Wetter, Stanislav N. Tolkachjov
Journal of the American Academy of Dermatology. 2020; 82(6): 1346
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Article Figures

 Article Access Statistics
    PDF Downloaded236    
    Comments [Add]    
    Cited by others 2    

Recommend this journal